The SAR studies to optimise both potency and rate of clearance in the rat for a series of pyrimidine and pyridine based VLA-4 antagonists are described.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0960-894x(02)00241-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!